Table 3.
The association between protein expression of TNC and cancer stem cell makers in colorectal cancer
| Variable | n | TNC (−)n (%) | TNC (+)n (%) | χ2 | R | P |
|---|---|---|---|---|---|---|
| CD133 | 0.019 | − 0.014 | 0.891 | |||
| Negative | 18 | 10 (55.6) | 8 (44.4) | |||
| Positive | 82 | 47 (57.3) | 35 (42.7) | |||
| CD44 | 0.532 | 0.073 | 0.466 | |||
| Negative | 69 | 41 (59.4) | 28 (40.6) | |||
| Positive | 31 | 16 (51.6) | 15 (48.4) | |||
| LSD1 | 4.910 | 0.222 | 0.027 | |||
| Negative | 25 | 19 (76.0) | 6 (24.0) | |||
| Positive | 75 | 38 (50.7) | 37 (49.3) | |||
| SOX2 | 0.041 | 0.020 | 0.840 | |||
| Negative | 10 | 6 (60.0) | 4 (40.0) | |||
| Positive | 90 | 51 (55.7) | 39 (43.3) | |||
| SOX9 | 0.639 | 0.080 | 0.424 | |||
| Negative | 7 | 5 (71.4) | 2 (28.6) | |||
| Positive | 93 | 52 (55.9) | 41 (44.1) |